A recent Ipsos survey of nearly 20,000 adults across 27 countries found that 74% are in favor of getting vaccinated against COVID-19. In France, over 40% expressed concerns, mainly about potential side effects.
More than 150 vaccines are under development worldwide to combat COVID-19. Five have advanced to phase 3 trials, the final stage before seeking regulatory approval. Russia announced on August 12 its "first" coronavirus vaccine, though its effectiveness remains unproven at scale.
While labs race ahead, public response is key. Ipsos surveyed 20,000 adults from 27 countries to gauge intentions.
Overall, 74% of respondents said they would get vaccinated against COVID-19 once available (37% strongly agree, 37% somewhat agree). Meanwhile, 26% disagreed (15% somewhat, 12% strongly).
Top intentions: China (97%), Brazil (88%), Australia (88%), India (87%). Lowest: Russia (54%), Poland (56%), Hungary (56%). France follows at 59% in favor.
Across all 27 countries, 59% doubt a vaccine will arrive by end of 2020.
Chinese respondents were most optimistic (87% expect one this year). In France, only 40% agree. Skeptics include Germans, Belgians, Japanese, and Poles (under 25%).
Ipsos also polled 5,000 non-vaccinators. Top reason: side effects (60% in France). Next: doubts on effectiveness (33% in France).
Third: feeling low personal risk (19% global, 14% France). Last: general anti-vaccine views (17% global, 24% France).
